The effectiveness of antihistamine and antileukotriene drugs in the treatment of irritable bowel syndrome with the reveled concomitant allergic conditions
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
Objective — to rectify the histamine role in the pathogenesis of irritable bowel syndrome (IBS) and to establish the efficacy of antihistamine and antileukotriene drugs in the complex treatment of IBS patients. Materials and methods. The study was conducted in the years 2016 to 2017 on the basis of the Department of Internal Medicine N 1 of O. O. Bogomolets National Medical University. The examinations involved 150 IBS patients with the mean age 40.8 ± 2.1 years, from them 106 (72.6 %) women. Patients with the reveled concomitant allergic conditions (84 (56 %)) were divided into two groups. The first group (n = 40) received the standard basictherapy depending on the IBS sub-type, the second group (n = 44) received the additional combined anti-inflammatory treatment with Quifenadine (25 mg 3 times a day) in combination with Montelukast (10 mg once a day). The groups were matching by the mean age and gender ratio. The treatment efficacy was assessed after 1 month. Results. It has been shown that in IBS patients, histamine levels were significantly higher (р ≤ 0.05), and blood serum enzyme diaminoxidase levels (р ≤ 0.05) were lower, that may indicate the presence of histamine intolerance in some groups of patients. The additional administration of quifenadine and montelukast resulted not only in the significant reduction of allergic complaints, but also in the decrease in serum histamine level (р ≤ 0.05), increased treatment effectiveness of the IBS patients, in particular, significant reduction in the intensity of pain and diarrheal syndrome (р ≤ 0.001) and also increased indicators of the general health, vitality and physical condition of the patients (р ≤ 0.05). Conclusions. Montelukast, as well as the III generation antihistamines, may be a method of treatment of patinets with IBS and allergic conditions, but to provide the clinical recommendations, the additional and well designed trials should be conducted in other gastroenterological and allergological centers.
Authors and Affiliations
A. R. Levchenko
Keywords
Related Articles
- EP ID EP574912
- DOI 10.30978/MG-2019-2-22
- Views 125
- Downloads 0
Gastroesophageal reflux disease in patients with metabolic syndrome: the peculiarities of clinical course and the modern approaches to treatment
The article presents a data on prevalence of gastroesophageal reflux disease and Barrett’s esophagus in patients with metabolic syndrome. The main etiopathogenetic mechanisms of formation and modern approaches to therapy...
A clinical case of eosinophilic esophagitis combined with macroamylasemia
Eosinophilic esophagitis is one of the most prevalent esophageal diseases and the leading cause of dysphagia and food impaction in children and young adults. The authors presented a clinical case of a patient with eosino...
V Maastricht consensus: the personified approach to the eradication therapy with account of the regional peculiarities of Ukraine
The key provisions of the V Maastricht Consensus on the diagnosis and treatment of Helicobacter pylori infection have been considered. The analysis has been performed for the main results of eradication therapy for the l...
Non-cirrhotic portal hypertension: clinical case and literature review
Non-cirrhotic portal hypertension can be caused by many factors. The authors presented a clinical case of portal hypertension that was eventually determined to be caused by repeated microthrombotic events on the basis of...
The drug induced liver injury: tactics of diagnosis and treatment
The article presents data of the drug induced liver injury, that plays an important role in the general structure of liver pathology. The basic directions of therapeutic correction of the drug induced liver injury been p...